Article Text

Download PDFPDF

Validity of self-reported myocardial infarction and stroke in regions with Sami and Norwegian populations: the SAMINOR 1 Survey and the CVDNOR project
  1. Bent-Martin Eliassen1,
  2. Marita Melhus1,
  3. Grethe S Tell2,3,
  4. Kristin Benjaminsen Borch4,
  5. Tonje Braaten4,
  6. Ann Ragnhild Broderstad1,5,
  7. Sidsel Graff-Iversen4,6
  1. 1Faculty of Health Sciences, Department of Community Medicine, Centre for Sami Health Research, UiT The Arctic University of Norway, Tromsø, Norway
  2. 2Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
  3. 3Norwegian Institute of Public Health, Bergen, Norway
  4. 4Faculty of Health Sciences, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway
  5. 5Department of Medicine, University Hospital of Northern Norway, Harstad, Norway
  6. 6Norwegian Institute of Public Health, Oslo, Norway
  1. Correspondence to Dr Bent-Martin Eliassen; bent-martin.eliassen{at}uit.no

Abstract

Objective Updated knowledge on the validity of self-reported myocardial infarction (SMI) and self-reported stroke (SRS) is needed in Norway. Our objective was to compare questionnaire data and hospital discharge data from regions with Sami and Norwegian populations to assess the validity of these outcomes by ethnicity, sex, age and education.

Design Validation study using cross-sectional questionnaire data and hospital discharge data from all Norwegian somatic hospitals.

Participants and setting 16 865 men and women aged 30 and 36–79 years participated in the Population-based Study on Health and Living Conditions in Sami and Norwegian Populations (SAMINOR) 1 Survey in 2003–2004. Information on SMI and SRS was available from self-administered questionnaires for 15 005 and 15 088 of these participants, respectively. We compared this information with hospital discharge data from 1994 until SAMINOR 1 Survey attendance.

Primary and secondary outcomes Sensitivity, specificity, positive predictive value (PPV), negative predictive value and κ.

Results The sensitivity and PPV of SMI were 90.1% and 78.9%, respectively; the PPV increased to 93.1% when all ischaemic heart disease (IHD) diagnoses were included. The SMI prevalence estimate was 2.3% and hospital-based 2.0%. The sensitivity and PPV of SRS were 81.1% and 64.3%, respectively. The SRS prevalence estimate was 1.5% and hospitalisation-based 1.2%. Moderate to no variation was observed in validity according to ethnicity, sex, age and education.

Conclusions The sensitivity and PPV of SMI were high and moderate, respectively; for SRS, both of these measures were moderate. Our results show that SMI from the SAMINOR 1 Survey may be used in aetiological/analytical studies in this population due to a high IHD-specific PPV. The SAMINOR 1 questionnaire may also be used to estimate the prevalence of acute myocardial infarction and acute stroke.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors SG-I introduced the idea for the study. B-ME performed the statistical analyses and drafted the manuscript. MM performed the linkage of data sources and assisted with the statistical analyses. MM, SG-I, KBB, TB, ARB and GST helped draft the manuscript.

  • Funding The SAMINOR 1 Survey was financed by the Ministry of Health and Care services. CVDNOR received funding from Nasjonalforeningen for folkehelsen. The North Norwegian Regional Health Authority provides B-ME's postdoctoral research grant.

  • Competing interests None declared.

  • Ethics approval The SAMINOR 1 Survey was approved by the Regional Committee for Medical Research Ethics, region North (REC North) and the Norwegian Data Protection Authority. CVDNOR as a project was approved by the Regional Committee for Medical and Health Research Ethics, region west (REC west). This validation study was approved by REC North.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles